Cash Flow Statement

Amortizatization of Intangibles Capital Expenditures Cash from Financing Activities Cash from Investing Activities Cash from Operations Change in Account Payables Change in Accured Expenses Change in Acquisitions & Divestments Change in Cash Change in Receivables Depreciation & Amortization (CF)Free Cash Flow Gains from Investment Securities Net Cash Flow Net Income Non-cash Items Other financing activities Share-based Compensation Shares Issued

Daily Values

Others

Ratios

Upstream Bio (UPB) Capital Expenditures (2024 - 2025)

Upstream Bio (UPB) has 2 years of Capital Expenditures data on record, last reported at $64000.0 in Q3 2025.